B Pellegrino, A Musolino, M Tiseo. Show Affiliations »
Abstract
Entities: Chemical Disease Species
Mesh： See more » Antibodies, Monoclonal/administration & dosageAntibodies, Monoclonal/adverse effectsAntineoplastic Agents/administration & dosageAntineoplastic Agents/adverse effectsCarcinoma, Non-Small-Cell Lung/bloodCarcinoma, Non-Small-Cell Lung/drug therapyCarcinoma, Non-Small-Cell Lung/immunologyCryoglobulinemia/chemically inducedCryoglobulinemia/immunologyHumansLung Neoplasms/bloodLung Neoplasms/drug therapyLung Neoplasms/immunologyMaleMiddle AgedNivolumabProgrammed Cell Death 1 Receptor/antagonists & inhibitorsProgrammed Cell Death 1 Receptor/immunology
Substances： See more » Antibodies, MonoclonalAntineoplastic AgentsPDCD1 protein, humanProgrammed Cell Death 1 ReceptorNivolumab
Year: 2017 PMID： 28383638 DOI： 10.1093/annonc/mdx126
Source DB: PubMed Journal: Ann Oncol ISSN： 0923-7534 Impact factor: 32.976